{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T12:57:33Z","timestamp":1791464253405,"version":"4.3.4"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100010795","name":"Chugai","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010795","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Kaken"},{"DOI":"10.13039\/100003454","name":"Taiho","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100003454","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002973","name":"Daiichi-Sankyo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002973","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004820","name":"Mochida","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004820","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Meiji Yasuda Health Development Foundation"},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Nippon Kayaku"},{"DOI":"10.13039\/501100004095","name":"Kyowa Kirin","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004095","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003769","name":"Eisai","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003769","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013420","name":"Tsumura","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013420","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Beyer"},{"name":"Aska"},{"DOI":"10.13039\/100014424","name":"Meiji","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014424","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009475","name":"Fuji","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009475","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100013420","name":"Tsumura","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100013420","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100010793","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010793","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Kissei"},{"DOI":"10.13039\/501100005612","name":"Shionogi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005612","id-type":"DOI","asserted-by":"publisher"}]},{"name":"GenoDive"},{"name":"CMIC"},{"name":"Shinnihonseiyaku"},{"name":"MSD"},{"DOI":"10.13039\/100008373","name":"Takeda","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008373","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006483","name":"Abbvie","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Ono"},{"DOI":"10.13039\/501100003769","name":"Eisai","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003769","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012030","name":"Yakult","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012030","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Bayer"},{"name":"Aska"},{"name":"Zeria"},{"name":"BrightPath Biotherapeutics"},{"name":"GSK"},{"name":"Health Sciences Research","award":["H16-035"],"award-info":[{"award-number":["H16-035"]}]},{"name":"Health Sciences Research","award":["H19\u2013028"],"award-info":[{"award-number":["H19\u2013028"]}]},{"name":"Health Sciences Research","award":["H22-020"],"award-info":[{"award-number":["H22-020"]}]},{"DOI":"10.13039\/100000884","name":"Cancer Research","doi-asserted-by":"publisher","award":["17S-1"],"award-info":[{"award-number":["17S-1"]}],"id":[{"id":"10.13039\/100000884","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000884","name":"Cancer Research","doi-asserted-by":"publisher","award":["17S-5"],"award-info":[{"award-number":["17S-5"]}],"id":[{"id":"10.13039\/100000884","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000884","name":"Cancer Research","doi-asserted-by":"publisher","award":["18-06"],"award-info":[{"award-number":["18-06"]}],"id":[{"id":"10.13039\/100000884","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000884","name":"Cancer Research","doi-asserted-by":"publisher","award":["20S-1"],"award-info":[{"award-number":["20S-1"]}],"id":[{"id":"10.13039\/100000884","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000884","name":"Cancer Research","doi-asserted-by":"publisher","award":["20S-6"],"award-info":[{"award-number":["20S-6"]}],"id":[{"id":"10.13039\/100000884","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare, Japan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Cancer Center Research and Development Funds","award":["23-A-16"],"award-info":[{"award-number":["23-A-16"]}]},{"name":"National Cancer Center Research and Development Funds","award":["23-A-17"],"award-info":[{"award-number":["23-A-17"]}]},{"name":"National Cancer Center Research and Development Funds","award":["26-A-4"],"award-info":[{"award-number":["26-A-4"]}]},{"name":"National Cancer Center Research and Development Funds","award":["29-A-3"],"award-info":[{"award-number":["29-A-3"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.ejca.2020.02.020","type":"journal-article","created":{"date-parts":[[2020,3,13]],"date-time":"2020-03-13T06:23:05Z","timestamp":1584080585000},"page":"114-125","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":213,"special_numbering":"C","title":["Comparison of survival between primary debulking surgery and neoadjuvant chemotherapy for stage III\/IV ovarian, tubal\u00a0and peritoneal cancers in phase III randomised trial"],"prefix":"10.1016","volume":"130","author":[{"given":"Takashi","family":"Onda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toyomi","family":"Satoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gakuto","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiaki","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Kasamatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Nakanishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomonori","family":"Mizutani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Takehara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aikou","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimio","family":"Ushijima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei","family":"Kawana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harushige","family":"Yokota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Takano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1372-6145","authenticated-orcid":false,"given":"Hiroyuki","family":"Kanao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoh","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaichiro","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuo","family":"Yaegashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiharu","family":"Kamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Yoshikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.ejca.2020.02.020_bib1","first-page":"S161","article-title":"Carcinoma of the ovary. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer","volume":"95","author":"Heintz","year":"2006","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.ejca.2020.02.020_bib2","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/1098-2388(200007\/08)19:1<42::AID-SSU7>3.0.CO;2-M","article-title":"Cytoreductive surgery for advanced stages of ovarian cancer","volume":"19","author":"Dauplat","year":"2000","journal-title":"Semin Surg Oncol"},{"key":"10.1016\/j.ejca.2020.02.020_bib3","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/0090-8258(91)90335-3","article-title":"Neoadjuvant chemotherapy and interval debulking for advanced epithelial ovarian cancer","volume":"42","author":"Jacob","year":"1991","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejca.2020.02.020_bib4","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1136\/ijgc-00009577-200111000-00007","article-title":"Neoadjuvant chemotherapy or primary surgery in advanced epithelial ovarian carcinoma","volume":"11","author":"Kayik\u00e7io\u1e21lu","year":"2001","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ejca.2020.02.020_bib5","first-page":"405","article-title":"Neoadjuvant chemotherapy for advanced epithelial ovarian carcinoma: a retrospective case-control study","volume":"23","author":"Vr\u0161\u010daj","year":"2002","journal-title":"Eur J Gynaecol Oncol"},{"key":"10.1016\/j.ejca.2020.02.020_bib6","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.ajog.2006.03.075","article-title":"Initial chemotherapy followed by surgical cytoreduction for the treatment of stage III\/IV epithelial ovarian cancer","volume":"195","author":"Everett","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejca.2020.02.020_bib7","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1006\/gyno.1998.5236","article-title":"Neoadjuvant chemotherapy for advanced ovarian cancer: long-term survival","volume":"72","author":"Schwartz","year":"1999","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejca.2020.02.020_bib8","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1093\/annonc\/mdg003","article-title":"Results of interval debulking surgery in advanced stage ovarian cancer: an exposed-non-exposed study","volume":"14","author":"Morice","year":"2003","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejca.2020.02.020_bib9","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ygyno.2006.11.025","article-title":"Neoadjuvant chemotherapy lessens surgical morbidity in advanced ovarian cancer and leads to improved survival in stage IV disease","volume":"105","author":"Hou","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejca.2020.02.020_bib10","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1056\/NEJMoa0908806","article-title":"Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer","volume":"363","author":"Vergote","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2020.02.020_bib11","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0140-6736(14)62223-6","article-title":"Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial","volume":"386","author":"Kehoe","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.ejca.2020.02.020_bib12","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1093\/jjco\/hym145","article-title":"Phase III trial of upfront debulking surgery versus neoadjuvant chemotherapy for stage III\/IV ovarian, tubal and peritoneal cancers: Japan Clinical Oncology Group Study JCOG0602","volume":"38","author":"Onda","year":"2008","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.ejca.2020.02.020_bib13","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ejca.2016.05.017","volume":"64","author":"Onda","year":"2016","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2020.02.020_bib14","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ygyno.2008.12.027","article-title":"Feasibility study of neoadjuvant chemotherapy followed by interval debulking surgery for stage III\/IV ovarian, tubal, and peritoneal cancers: Japan Clinical Oncology Group Study JCOG0206","volume":"113","author":"Onda","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejca.2020.02.020_bib15","doi-asserted-by":"crossref","first-page":"103","DOI":"10.2307\/2529712","article-title":"Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial","volume":"31","author":"Pocock","year":"1975","journal-title":"Biometrics"},{"key":"10.1016\/j.ejca.2020.02.020_bib16","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1056\/NEJM199503093321002","article-title":"The effect of debulking surgery after induction chemotherapy on the prognosis in advanced epithelial ovarian cancer. Gynecological Cancer Cooperative Group of the European Organization for Research and Treatment of Cancer","volume":"332","author":"van der Burg","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2020.02.020_bib17","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1056\/NEJMoa041125","article-title":"Secondary surgical cytoreduction for advanced ovarian carcinoma","volume":"351","author":"Rose","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2020.02.020_bib18","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006014.pub5","article-title":"Interval debulking surgery for advanced epithelial ovarian cancer (Review)","volume":"10","author":"Tangjitgamol","year":"2010","journal-title":"Cochran Database Syst Rev"},{"key":"10.1016\/j.ejca.2020.02.020_bib19","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1016\/S1470-2045(18)30566-7","article-title":"Neoadjuvant chemotherapy versus debulking surgery in advanced tubo-ovarian cancers: pooled analysis of individual patient data from the EORTC 55971 and CHORUS trials","volume":"19","author":"Vergote","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2020.02.020_bib20","doi-asserted-by":"crossref","first-page":"3955","DOI":"10.1245\/s10434-013-3091-6","article-title":"Timing and pattern of recurrence in ovarian cancer patients with high tumor dissemination treated with primary debulking surgery versus neoadjuvant chemotherapy","volume":"20","author":"Petrillo","year":"2013","journal-title":"Ann Surg Oncol"},{"issue":"Suppl 3","key":"10.1016\/j.ejca.2020.02.020_bib21","doi-asserted-by":"crossref","first-page":"S971","DOI":"10.1245\/s10434-015-4623-z","article-title":"Neoadjuvant Chemotherapy Followed by Interval Debulking Surgery and the Risk of Platinum Resistance in Epithelial Ovarian Cancer","volume":"22","author":"da Costa","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejca.2020.02.020_bib22","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ygyno.2013.01.009","article-title":"Platinum resistance after neoadjuvant chemotherapy compared to primary surgery in patients with advanced epithelial ovarian carcinoma","volume":"129","author":"Rauh-Hain","year":"2013","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejca.2020.02.020_bib23","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ygyno.2010.09.010","article-title":"Identification of patient groups at highest risk from traditional approach to ovarian cancer treatment","volume":"120","author":"Aletti","year":"2011","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejca.2020.02.020_bib24","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/jso.23171","article-title":"Neoadjuvant chemotherapy (NACT) is an effective way of managing elderly women with advanced stage ovarian cancer (FIGO Stage IIIC and IV)","volume":"107","author":"Glasgow","year":"2013","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.ejca.2020.02.020_bib25","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.ygyno.2014.07.002","article-title":"A multicenter prospective trial evaluating the ability of preoperative computed tomography scan and serum CA-125 to predict suboptimal cytoreduction at primary debulking surgery for advanced ovarian, fallopian tube, and peritoneal cancer","volume":"134","author":"Suidan","year":"2014","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejca.2020.02.020_bib26","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ejca.2016.01.017","article-title":"Phase III randomised clinical trial comparing primary surgery versus neoadjuvant chemotherapy in advanced epithelial ovarian cancer with high tumour load (SCORPION trial): Final analysis of peri-operative outcome","volume":"59","author":"Fagotti","year":"2016","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2020.02.020_bib27","doi-asserted-by":"crossref","first-page":"3460","DOI":"10.1200\/JCO.2016.68.6907","article-title":"Neoadjuvant Chemotherapy for\u00a0Newly Diagnosed, Advanced Ovarian Cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline","volume":"34","author":"Wright","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2020.02.020_bib28","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ygyno.2016.05.022","article-title":"Neoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline","volume":"143","author":"Wright","year":"2016","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejca.2020.02.020_bib29","doi-asserted-by":"crossref","first-page":"3854","DOI":"10.1200\/JCO.2016.68.1239","article-title":"Use and Effectiveness of Neoadjuvant Chemotherapy for Treatment of Ovarian Cancer","volume":"34","author":"Meyer","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2020.02.020_bib30","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.ygyno.2016.09.002","article-title":"Trends in the use of neoadjuvant chemotherapy for advanced ovarian cancer in the United States","volume":"143","author":"Melamed","year":"2016","journal-title":"Gynecol Oncol"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804920300745?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804920300745?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T20:27:09Z","timestamp":1760732829000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804920300745"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":30,"alternative-id":["S0959804920300745"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2020.02.020","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of survival between primary debulking surgery and neoadjuvant chemotherapy for stage III\/IV ovarian, tubal\u00a0and peritoneal cancers in phase III randomised trial","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2020.02.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}